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Cataract is first of the five most common causes of blindness and vision impairment (poor 
night vision, fading colours and haloes around light) worldwide. It is followed by glaucoma, 
macular degeneration, diabetic retinopathy and trachoma. Prevention of blindness remains one 
of the most important areas of research in the medical field. A blind person becomes a burden in 
the family and the community at large, and blindness also shortens life span.   
Cataract extraction with intraocular lens implant is the most common surgery worldwide. We 
live in a developing country where we need a balance between quality and safe health practises 
against cost-effective measures.  We need to increase the number of cataract extractions in order 
to decrease vision impairment and blindness.  At the same time, we need to find cost-effective 
ways so that this procedure does not deplete the health budget. One way of decreasing costs is 
to reuse equipment after cataract surgery.  
Cataract extraction has evolved over many years. It is one of the oldest surgical procedures, 
first documented in the fifth century BC. The most significant change which marked a modern 
era victory was the introduction of phacoemulsification (phaco) in 1967. Phacoemulsification 
involves the breakdown of the nucleus using ultrasonography, irrigation and aspiration of the 
lens material.  This technique has fewer complications including less wound problems, the 
procedure is sutureless and the risk of endophthalmitis and suprachoroidal haemorrhage is 
significantly decreased.  
Two phacoemulsification tubes are connected to a phaco probe, one tube has fluid for 
irrigation and the other tube aspirates lens material and fluid. Both tubes do not enter the eye, 
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only the probe does. The phaco probe can therefore not be reused without being first sterilised.  
The tubes, however, should remain sterile and could potentially be reused. This study looks 
particularly at the sterility of the irrigation tube which carries BSS (Balanced Salt Solution) to the 
eye.  
This observational descriptive prospective study was conducted at Edendale Hospital and 
Greys Hospital in the city of Pietermaritzburg (PMB). These hospitals are part of the PMB 
metropolitan complex in South Africa. In this complex there is no standard protocol with regards 
to whether we may reuse phaco tubing or not. Greys Hospital does not reuse tubing (they use 
one “phaco pack” per theatre case) whereas Edendale Hospital reuses the tubing: one tubing for 
3 cases.  For this study the tip of each tube was sent for culture to check for micro-organisms. 
Two unused phaco tubings were sent as controls. We used the same laboratory for all analyses.  
Guidelines from the manufacturer state that phaco packs (the tubing is found inside this pack) 
are for single use only (1). There is, however, lack of scientific proof to back this guideline. We 
endeavoured to assess whether reusing phaco tubing has a negative impact on the sterility (and 
therefore safety) or not. If not, then reusing the phaco tubes could be widely adopted in an effort 
to save money while maintaining patient safety.  
In summary, the aim of this observational descriptive prospective study is to assess if 
phacoemulsification tubing remains sterile during sequential phacoemulsification procedures. 
The objectives are to investigate whether there is a difference in growth of micro-organisms from 
phaco tubing that are used at the two sites; to investigate and compare micro-organisms, if 
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identified, from each specimen; and to gather evidence for a future protocol regarding reusing 
phaco tubing for sequential phacoemulsification. 
More than half of all specimens in each group showed growth of the bacillus species and 
other organisms as a result of contamination. This study showed that there was a non-statistical 
difference between the contamination rates of the tubes from both hospitals. Although a 
statistical significance was not shown, this result is of great clinical significance. It highlights the 
need for further research into patient safety as our study showed significant contamination. 
Patient safety cannot be concluded from this study.  A protocol to be followed by all the PMB 
complex hospitals cannot be drawn up as yet as further research into patient safety is warranted. 
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CHAPTER 1: The Review of Literature 
  
The practise of reusing single-use devices is done worldwide. In America it is subject to Food 
and Drug Administration oversight (1). Although it is anecdotally considered to be safe and 
effective, little published evidence is available on safety and efficacy (2). In Australia, a study by 
infection-control experts at the Woden Valley Hospital in Canberra indicated that reuse was 
occurring in 38% of all respondents (Med J Aust 1996; 164: 533-36)(3). Reuse occurred in more 
large metropolitan hospitals (in 64% of those with more than 300 beds) than in smaller 
metropolitan hospitals (in 41% of hospitals with fewer than 300 beds), or in private hospitals 
(32%) (4). 
In a third world country like India, reuse of medical equipment marked for single-use is also 
quite common. A study was done in India which assessed if there was a correlation between 
reusing single-use devices and adverse effects in patients post percutaneous transluminal 
coronary angioplasty.   The study took place in two hospitals, one with primarily high income 
earners and one with low income earners. Patients were admitted for the same indication. 
Adverse effects were categorised into serious (death, pyogenic infections and extended hospital 
stay) and non-serious (swelling, bleeding from site, haematoma, oozing from site) adverse 
effects. Anecdotal information suggests that hospitals with low income earners were found to 




There was, however, no difference in the number of adverse effects between the two 
hospitals, despite the significant difference in the number of single-use devices per procedure 
(5). 
Post phacoemulsification endophthalmitis is one of the most severe complications of cataract 
surgery and it may lead to permanent blindness. Micro-organisms can be introduced in almost 
any step during surgery. Studies have found that wound incisions are the leading pathway for 
introducing flora into the eye (6). Lack of equipment sterility is an area where micro-organisms 
can be introduced. Sterile equipment is pre-packed to ensure quicker access and usage while 
maintaining sterility.  
 All state hospitals in the PMB complex utilize the Infinity™ system (Alcon Laboratories) which 
uses a single-use pack for each procedure. In the state phaco packs cost R656.67 per pack, the 
second most expensive consumable in our setting. Each sterile pack consists of a cartridge with 
irrigation fluid attachments (which fits into the phaco machine) as well as tubing, which fits into 
the autoclaveable hand piece. Only the hand piece is ever in contact with the patient’s eye. The 
cartridge and tubing could therefore theoretically remain sterile for many cases if handled with 
care. 
 A study in the European Journal of Ophthalmology in 2012 aimed to determine if there was 
microbial contamination of the irrigating fluids at the time of phacoemulsification after the use 
of topical povidone-iodine and antibiotics prophylaxis (7). After each case fluid was collected and 
sent for microbiology analysis. Results showed that there was indeed contamination of irrigating 
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fluid but preoperative use of antibiotics decreased the rate of endophthalmitis infection to 
practically zero. 
An article by Carol Rhuel, which was published in the Eucomed white paper in December 2009 
explored whether outbreaks of Toxic Anterior Segment Syndrome (TASS) may be caused by 
contaminated devices (8). In this article, photos were taken with a scanning electron microscope 
and they were used to illustrate the increasing signs of degradation with continuous phaco tip 
reuse. The photos showed particulate matter which gathered on the phaco tip. This raised 
concerns about those small surgical devices that cannot be cleaned sufficiently for reuse without 
damaging them. The particulate matter on them can be introduced into the next patient’s eye 
and could potentially also harbour micro-organisms. 
There have been cases of postoperative endophthalmitis associated with equipment 
contamination. One study’s purpose was to set up a model for the assessment, investigation and 
management of an atypical outbreak of infectious endophthalmitis of unknown cause in London 
in 2003 (9). A multidisciplinary infection control team was formed with the aim of identifying 
potential causative factors. These factors included analysing the theatre and its surrounding 
environment, pre-operative preparation, intra-operative theatre and surgical practices, post-
operative practices, equipment maintenance guidelines, cleaning and sterilisation practices and 
microbiological screening. Five cases of endophthalmitis following uncomplicated 
phacoemulsification, by different surgeons, were noted over a 7-month period. Three cultures 
grew Streptococcus viridans of different strains, 1 culture grew Staphylococcus aureus and no 
organisms grew on the last culture. Without a single causative factor, it was postulated that it 
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was a combined effect of many possible factors that led to increased bacterial load and 
subsequent infection rate. Recommendations were made which included new cleaning protocols 
to prevent the build-up of debris on the phacoemulsification tubing.  
In another article by Lesley et al (10) the importance of meticulous cleaning of phaco hand 
pieces to prevent endophthalmitis was elaborated. Automated flushing should be superior to 
manual cleaning of the instruments in preventing interpatient transfer of infection. Automated 
flushing did not, however, eliminate contamination but it only decreased it (11). In other 
branches of medicine manual cleaning and flushing of instruments with small lumens prior to 
sterilization proved more effective in eliminating inter-patient contamination.  
Low temperature sterilization has been highlighted since the development of plastic single-
use medical devices and the appearance of more sophisticated endoscopic tools whose 
constitutive materials could not bear high temperature processing (12). The criteria of gaseous 
proceedings, alkylating and oxidizing agents as well as new technologies based on the use of cold 
plasma, were reviewed. Drawbacks of alkylating agents include toxicity to staff, patients and 
environment, mutagenicity and dangers of handling. Drawbacks of oxidizing agents include 
corrosive effects on almost any material but with proper use they are promising. In recent years, 
their efficacy has been enhanced by using cold plasma to increase production of free radicals. 
There are no studies that have looked specifically into re-using phacoemulsification irrigation 
tubing in isolation. A study was done in Brazil that looked into viral contamination during 
sequential phacoemulsification surgeries in an experimental model. The purpose of the study 
was to determine the incidence of Piry virus contamination among surgical instruments used with 
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disposable accessories for phacoemulsification during sequential surgeries (13). Four pigs eyes 
were contaminated with Piry virus and the other four eyes were not. Phacoemulsification 
surgeries were done on all eight eyes alternating between contaminated and non-contaminated 
eyes. The hand piece, irrigation and aspiration tubes were reused, the operating fields, gloves, 
scalpels, tweezers, needles, syringes, tip and bag collector from the phacoemulsification machine 
were exchanged. In their results they analysed specimens from the collector bags, the tips, 
irrigation and aspiration system. From their irrigation system, a sample from a non-contaminated 
eye (1/4) was positive and in their aspiration system two samples from non-contaminated eyes 
were positive. In the collector bag two samples from non-contaminated eyes were positive. At 
the tip two samples from non-contaminated eyes were positive. They also found two samples 
from the anterior chamber of non-contaminated eyes to be positive post-surgery. The conclusion 
was there was transfer of genetic material of Piry virus during sequential phacoemulsification 
where the tip, irrigation and aspiration systems were reused between surgeries (14). 
There are studies that have looked into re-using extra ocular single-use devices. These studies 
include a study done in the UK, where they looked into re-using single-use laparoscopic 
instruments for cholecystectomy. This was a single published randomised controlled study which 
found no significant differences in outcome when comparing new and reprocessed single-use 
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Original Research Article - full structure 
Title: A microscopic analysis of single-use VERSUS multi-used phacoemulsification tubing in 
maintaining sterility and patient safety 
The Abstract 
 
Background: The Pietermaritzburg complex in South Africa does not have a uniform protocol 
regarding reuse of phacoemulsification tubing. Each hospital in the complex has its own 
guidelines, based on manufacture recommendation and cost-saving measures.  There is no 
definitive scientific evidence proving that reusing phaco tubing will harm patients.  
Aim: To assess if phacoemulsification tubing remains sterile during sequential 
phacoemulsification. 
Settings: The study was conducted at Edendale and Greys Hospitals in the Pietermaritzburg 
complex in KwaZulu-Natal, South Africa. At Greys Hospital new phacoemulsification tubing is 
used for each case. At Edendale Hospital, phacoemulsification tubing is reused on three 
sequential patients in one slate. 
Method: This was an observational descriptive prospective study. It was done over 4 months. 
Data collection was from 31/03/2019 until 18/07/2019 from both hospitals. Routine 
phacoemulsification was done at each hospital as per hospital guidelines. At the end of the 
surgery, the tips of the tubing were cut off, placed in a sterile specimen container and sent to the 
laboratory for culture and microscopy. Results were compared as one hospital re-uses phaco 




Results: A total of 26 single-use tubings were analysed. 12 out 26 tubings (46.2%) grew no 
organisms; 5 out of 26 tubings (19.2%) grew bacillus species; a variety of other micro-organisms 
were found in less than 1% of tubings. A total of 41 multiple-use tubings were sent for analysis. 
17 out of 41 tubings (41.5%) grew no organisms; 7 out of 41(17.1%) tubings grew bacillus species. 
A variety of other micro-organisms were found in less than 5% of tubings. Pre-used tubings did 
not grow any micro-organisms. 
Conclusion: A p value less than of 0.05% was accepted as statistically significant. Comparing 
the two hospitals, tubings which grew no organisms were 46.2% (single-use) versus 41.5% 
(multiple-use). This gives a statistically non-significant p value of 0.70394. Tubing which grew 
bacillus species were 19.2% (single-use) versus 17.1% (multiple-use) (p = 0.82588).  Comparing a 
variety of other micro-organisms also gives a p value of 0.75656. This implies that 
phacoemulsification tubing is significantly contaminated after just one use. Although no 
statistical difference was found between the two groups, a contamination rate of over 40% is of 
great concern. There are contributing factors which may have influenced this result including the 
fact that our specimen containers, even though they are the standard specimen containers in our 
hospitals, are not really sterile. Specimen handling in theatre and in the laboratory could also 
have contributed to contamination.  In our setting, phaco tubing does not seem to remain sterile 







The Pietermaritzburg complex comprises of three hospitals. Two of them participated in the study. 
The third one did not offer phacoemulsification at the time of the study. The hospitals do not have a 
uniform protocol regarding reuse of phacoemulsification tubing. Each hospital bases its protocol either 
solely on manufacture recommendation or a combination of manufacture recommendation and cost-
saving measures. Theatre staff from Greys Hospital follows the manufacturer guidelines: Phaco packs are 
sold as single-use items.   
It is a directive from the provincial Department of Health (DOH) to save costs. One solution is to buy 
cheaper equipment or to opt to perform surgical techniques that do not require expensive equipment. 
There is a suggestion from DOH to the ophthalmology departments to rather perform more extracapsular 
lens extractions, which cost less than phacoemulsification. A secondary objective of this study is to make 
a protocol with regards to reusing items labelled by the manufacturer as single-use. Hopefully this study 
will form a basis for more research into reusing items labelled as single use items by the manufacturer. 
 There is little scientific evidence evaluating whether reusing phaco tubing will harm patients. A 
previous study found that micro-organisms could be transferred from infected to non-infected eyes during 
sequential phacoemulsification but they only analysed probes, irrigation and aspiration fluids. There is no 
published directive regarding re-use of single-use phaco packs.   
The aim of the study is to assess if phacoemulsification tubing remains sterile during sequential 
phacoemulsification. The objective is to investigate if there is growth of micro-organisms from phaco 
tubings at the two sites and to compare the micro-organisms after single vs multiple use. 
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 In this study the phaco probes are autoclaved before being reused but the tubing are not. Microscopic 
analysis of the tubing should serve as evidence for drafting a standard protocol for the Pietermaritzburg 




Research method and design 
 
Study design and setting  
This was an observational descriptive prospective study. It was done over 4 months from 
31/03/2019 until 18/07/2019. It was conducted at Greys Hospital and Edendale Hospital. Routine phaco 
procedure was done. Drapes, blades, knives and phaco probes were all sterilised before being reused. Re-
used tubing was not sterilized between cases.  Slates and procedures were not altered for the study. We 
used these two hospitals because they currently have different protocols on used phacoemulsification 
tubing. At Greys Hospital new phacoemulsification tubing was used for each case. At Edendale Hospital, 
phacoemulsification tubing was reused on three sequential patients on one slate. At the end of the 
case(s), just before the tubing was discarded (after each case at Greys Hospital and at the end of every 
third case at Edendale Hospital), a 5cm piece of irrigation tubing tip was cut off, placed in a sterile 
specimen container and sent to the laboratory for investigation. Two unused irrigation tubings were also 
sent to the laboratory for testing as controls. At the laboratory the specimens were incubated in a broth 
medium overnight then transferred on to Agar plates for culture.  
 
Study population and sampling strategy 
Theatre cases were booked as per standard departmental theatre slates. Slates are often booked 
months in advance. Specimens were collected as they become available at the end of the procedure(s). 
Unused irrigation tubing was also sent as specimen at the beginning of the study. 
 Inclusion criteria: all irrigation tubing used during that period, to be kept sterile and reach the 
laboratory in a sterile specimen container. 
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Exclusion criteria: any other techniques of cataract extraction including lens washout, extracapsular 
lens extraction and intracapsular lens extraction; known contaminated or known unsterile tubing.  
The intended sample size was 76 phacoemulsification tubing from three hospitals in the PMB 
complex. This was an estimated number of phacoemulsification surgeries done in the PMB complex in 
one month. One hospital did not offer the procedure at the time of the study due to lack of a surgeon so 
only two hospitals collected specimens and the sample size was decreased to 67. Collection took longer 
than one month due to unforeseen circumstances: These included lack of phaco packs at Greys Hospital 
in that period and theatre ran out of colour coded specimen bottles at Edendale Hospital. 41 irrigation 
tubings from Edendale Hospital were analysed and 26 tubings from Greys Hospital. Two unused and sterile 
tubings were donated by the manufacturer, Alcon Laboratories. The accuracy of our estimated average 
and range was calculated using statistical analysis. 
 
Data collection 
Standard specimen bottles and laboratory forms were left in theatre. Surgery was performed by 
different surgeons. Before discarding the tubing, the surgeon cut the 5mm piece with unused sterile 
scissors and inserted it into the specimen container. The specimen and the laboratory request forms were 
placed in clear laboratory plastic bags. Plastic bags, specimen bottles and request forms for the study were 
colour coded for easy identification of the hospital it originated from. Unused irrigation tubings were 
prepared by the author under sterile conditions, in the similar manner as the used irrigation tubings and 






   Data analysis was done with the statistician. The Z test, the difference of two proportions, was used 
for statistical analysis. A p-value of less than 0.05% was taken as statistically significant. We calculated the 




Patients were not enrolled for the study. No patient consent or record was required. The 
state laboratory was used to analyse our phacoemulsification tubing. Future patients could 
benefit because recommendations will be made to improve patient safety and/or improve cost-
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 AMENDMENTS REQUESTED:  
 Protocol states: in 4.5.2 (sample size)  
A total sample size is estimated at about 76phacoemulsification tubing which will be 
microscopically analysed. About 12 tubing will be collected from Northdale Hospital, 28 tubing 
from Greys Hospital and 40 tubing from Edendale Hospital.  
 
 Amendment requested  
Removal of Northdale Hospital as one of the participants in this study.   
 
 Reason for amendment  
This amendment is necessary as Northdale Hospital has suspended all ocular surgery as from 
01/04/2017. No phacoemulsification procedures will be done until a permanent doctor is 
employed by the hospital or Greys Hospital Eye Clinic has enough staff to send a doctor to 
Northdale to assist with ocular surgery.  This study will then only compare two hospitals, Greys 
Hospital and Edendale Hospital. This will not affect the study negatively as Edendale Hospital just 

















Phacoemulsification irrigation tubing was sent for microscopic analysis to show whether they 
remain sterile during sequential phacoemulsification. Results from specimen sent as controls 
showed no growth of micro-organisms. The results from single-used and multi-used tubings, as 
shown in table 1 and table 2, show that not all tubing remains sterile after phacoemulsification. 
Less than half of the tubings stay sterile as no micro-organisms were found in 41.5% (Edendale) 
and 46.2% (Greys). Tubings that did not remain sterile, grew a variety of micro-organisms as 
shown in table 1 and table 2. Most types of micro-organisms grew on only one or two tubing in 
each hospital. Bacillus species grew in multiple (5 or more) tubings. In comparing the two 
hospitals, clinically, Greys Hospital had more tubings which showed no growth of micro-
organisms than Edendale Hospital, but the difference was only 4.7%.  
The Z test, the difference of two proportions, was used for statistical analysis. The p value of 
less than 0.05% was taken as statistically significant. We calculated the confidence level using the 
formula Confidence level =P+/- 1.96 (P)(1-P)/n.  
Comparing the two hospitals, tubing which grew no organisms were 46.2% (single-use) versus 
41.5% (multiple-use). This gives a statistically non-significant p value of 0.70394. Tubing which 
grew bacillus species were 19.2% (single-use) versus 17.1% (multiple-use) (p = 0.82588), 
confidence level of 17.1% to 19.2% (single-use), versus confidence level of 14.52% to 19.68% 
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(multiple-use). Tubings which grew bacillus species give a p value of 0.82588.  In comparing a 
variety of other micro-organisms also gives a p value of 0.75656 which is statistically also not 












n % N % 
acinobacter baumanii complex - - 2 4.9% 
bacillus species 5 19.2% 7 17.1% 
coagulase neg staphylococcus and micrococcus - - 1 2.4% 
corynebacterium species 1 3.8% 1 2.4% 
granulicatella adiacens 1 3.8% - - 
klebsiella pneumonia - - 2 4.9% 
micrococcus luteus - - 2 4.9% 
micrococcus species and bacillus species 1 3.8% - - 
myroides species - - 1 2.4% 
pantoea species - - 1 2.4% 
pseudo stutzeri and coaguase neg staphylococcus 1 3.8% - - 
rhizobium radiobacter 1 3.8% - - 
serratia plymuthica 1 3.8% - - 
sphingomonas paucimobilis - - 2 4.9% 
staphylococcus auerues and staphylococcus lentus - - 1 2.4% 
staphylococcus capitis - - 1 2.4% 
staphylococcus cohnni 1 3.8% - - 
staphylococcus epidermidis 1 3.8% - - 
staphylococcus hominis and sphingomonas paucimobilis - - 1 2.4% 
staphylococcus warneri - - 1 2.4% 
streptococcus salivarium 1 3.8% 1 2.4% 
No growth 12 46.2% 17 41.5% 





The first documented complete surgical extraction of the lens from the eye was in 1748 in Paris(1). 
Over the past few decades major improvements were done by removing the cataract and leaving an intact 
posterior capsule behind(2). Wound reduction and introduction of sutures greatly improved results. The 
introduction of phacoemulsification has shortened surgery time and improved wound healing, but the 
costs of each surgery have risen drastically.  
The question of whether irrigation tubing remains sterile during sequential phacoemulsification 
tubing in our setting seems to have been answered. More than half of all phaco tubing is contaminated 
after use, even after only a single patient. This could be due to a variety of factors: Contamination of the 
tubings could have occurred during surgery or handling, from the time the tubings were opened for 
surgery to the time they were prepared for microscopy in the laboratory. 
Bacillus species was the most prevalent contaminant. All other species identified have never been 
associated with endophthalmitis. Bacillus species have been known as opportunist pathogens since the 
late nineteenth century. Isolation of this pathogen cannot be taken in isolation without taking the clinical 
picture into account (3). Certain subtypes of bacillus like bacillus anthrax and bacillus cereus are associated 
with terminal illnesses. B cereus causes destructive intraocular damage, severe keratitis, conjunctivitis, 
iridocyclitis, panophthalmitis, dacrocystitis and orbital abscess.  
 
Staphylococcus epidermidis has previously been regarded as an innocuous commensal microorganism 
on the human skin but nowadays it is seen as an important opportunistic pathogen. It is now the most 
frequent cause of nosocomial infections, at a rate about as high as that due to its more virulent cousin 
Staphylococcus aureus (4). Staphylococcus epidermidis is the most common source of infections on 
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indwelling medical devices.  This results from the fact that it is a permanent and ubiquitous colonizer of 
human skin, and the device gets contaminated during use (5). Staph epidermidis infections only rarely 
develop into life-threatening diseases. 
Corynebacterium diphtheria is linked to epidemic outbreaks in Russia in the 1990s. It has since seen 
a decline. Today, the more common scenario is non-diphtherial corynebacterial bacteremia associated 
with device infections (venous access catheters, heart valves, neurosurgical shunts, peritoneal catheters), 
as well as meningitis, septic arthritis, and urinary tract infections (6). 
More than half of our single- used and multi-used tubings were contaminated after surgery. This is 
clinically significant, even though many were “innocuous” micro-organisms. The results of single vs. 
multiple-use devices were however not statistically significant. Unused tubings were sterile as they did 
not grow any micro-organisms. These clinical results warrant further research in this field. 
 
Strengths 
The actual culture and microscopic analysis was done at a single recognized laboratory by qualified 
laboratory staff under the supervision of a qualified specialist microbiologist.  
The study was done in a real-world setting without changes to any of the procedures or methods and 







Sample size was kept small primarily due to cost and time constraints. A larger sample size could have had 
a more representative result. Duration was also a limiting factor, if more tubing were analysed over a long 
period a more representative result may have been seen.  
Different laboratory staff analysed the specimens. This could mean different technique and lack of proper 
insight of the study by the different laboratory technicians.  
Different theatre teams may also contribute to study limitation due to possible different specimen 
handling and sampling.  
All tubings were from the same company, Alcon. A comparison of tubings from different companies may 
have showed a different result. 
 
Implications and recommendations 
This study has laid a foundation for future studies on re-using phacoemulsification tubing. 
Phacoemulsification tubing seems to be contaminated even after only one use despite our efforts to 
keep the tips sterile during and between procedures. We recommend further research in this field with a 
larger sample size, one surgeon, use of one laboratory technician and microbiologist. This study has 
proven sterility of phaco tubings before use but has not proven sterility of phaco tubings even after single 






Microscopic analysis has shown that there may be growth of micro-organisms in tubings whether they 
have been used only once or multiple times. Unused tubings were confirmed sterile as no growth of micro-
organisms were found. No statistically significant difference between single-used and multi-used tubing 
was found. Less than half of tubings remained sterile after single and multi-use. Clinically the high rate of 
contamination is of great concern. Based on this study, multiple re-use of phacoemulsification tubing does 
not put patients at a much higher risk of infection than post single use. With post single use and multiple 
re-use safety was not guaranteed due to the high contamination rate. Tested pre-used tubings were not 
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Appendix 1: The final Study Protocol  
 
TITLE:  
A microscopic analysis of single-use VERSUS multi-used phacoemulsification tubing in maintaining 
sterility and patient safety 
Degree: MMed Ophthalmology 
Principal Investigator: Lungile Thandeka Ndlovu  
Student number: 206526069  
Contact details: 




Supervisor: Dr Carl-Heinz Kruse  




Statement of purpose 
The purpose of this comparative study is to evaluate the Pietermaritzburg guidelines regarding re-
using the phacoemulsification (phaco) tubing after cataract surgery. Currently each hospital in the 
Pietermaritzburg complex has its own guideline. The current guidelines are influenced by understanding 
how the machine works, maintaining sterility, preventing cross infection and trying to keep the costs low. 
The manufacturer recommends one phaco tubing for one patient however that is controversial, 
internationally. These recommendations are not evidence based and may just be for sales. Internationally, 
the risk of infection and appropriate sterilization procedures for machines with internal tubing is a 
controversial matter. 
In keeping with evidence based medicine, I am looking for microscopic evidence that will assist us in 
making standard guidelines based on scientific evidence. I will compare three groups from three hospitals 
in the Pietermaritzburg complex.  One hospital uses new phaco tubing for each case, the second hospital 
changes the phaco tubing after three cases and the last one uses one phaco tubing for the whole slate (six 
patients or more). Before the tubing is discarded we will cut off a piece and send it to be tested for micro- 
organisms. This study will be conducted in 2016. 
This project is necessary so as to have scientific evidence for choosing the specific guideline and set 
up a standard protocol. This study is looking at what the three hospitals have been doing for many years 
and finding common ground through scientific evidence. The results of this study will be relayed to the 





1. DEFINING THE RESEARCH PROBLEM 
A cataract is one of the leading causes of blindness worldwide. As a result the World Health 
Organisation put forward a target of how many cataracts need to be done per surgeon to eliminate 
blindness from cataract in 2020.  This was termed “Vision 2020”. 
To be in line with Vision 2020, high volume surgery centres have been set up.  
High-volume-cataract surgery centres need to be able to provide quality, safe and fast turnover. 
Safety of patients, in terms of sterility of the equipment, is what this study will be looking at. We want to 
evaluate whether sterility is maintained when the phacoemulsification tubing is re-used between 
patients. Are patients who receive used phacoemulsification tubing in any danger of exposure to 
contaminated equipment? This is controversial because the tubing with irrigating fluid (ingoing fluid) is 
separate from the tubing (outgoing fluid) that aspirates the lens material and they are both connected to 
the sterilised/autoclaved re-usable phaco probe.   
 
2. LITERATURE OVERVIEW AND MOTIVATION 
For patients, cataracts mean blurry vision, poor night vision, fading colours and haloes around lights. 
Phacoemulsification has become the leading technique of cataract extraction worldwide.   
Post phacoemulsification endophthalmitis is one of the severest complications of cataract surgery and 
it may lead to permanent blindness. Micro-organisms can be introduced in any step during surgery. 
Studies have found that wound incisions are the leading pathway for introducing flora into the eye (1). 
Equipment sterility is a wide area where micro-organisms can also be introduced. Equipment is often pre-
packed to ensure quicker access and usage.  
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The phaco machine has irrigation tubing and separate aspiration tubing. A study in the European 
Journal of Ophthalmology in 2012 aimed to determine if there was microbial contamination of the 
irrigating fluids at the time of phacoemulsification after the use of topical povidone-iodine and antibiotics 
prophylaxis (2). After each case fluid was collected and sent for microbiology analysis. Results showed 
that there was contamination of irrigating fluid but preoperative use of antibiotics decreased the rate of 
endophthalmitis infection. 
An article by Carol Rhuel, which was published in the Eucomed white paper in December 2009 
explored whether outbreaks of Toxic Anterior Segment Syndrome (TASS) may be caused by contaminated 
devices (3). In this article, photos were taken with a scanning electron microscope and they were used to 
illustrate the increasing signs of degradation with continuous phaco tip reuse. The photos showed 
particulate matter which gathered on the phaco tip. This raised concerns about those small surgical 
devices that cannot be cleaned sufficiently for reuse without damaging them. The particulate matter on 
them can be introduced into the next patient’s eye and could potentially also harbour micro-organisms. 
There have been cases of postoperative endophthalmitis associated with equipment contamination. 
One study’s purpose was to set up a model for the assessment, investigation and management of an 
atypical outbreak of infectious endophthalmitis of unknown cause in London in 2003 (4). A 
multidisciplinary infection control team was formed with the aim of identifying potential causative factors. 
These factors included analysing the theatre and its surrounding environment, pre-operative preparation, 
intra-operative theatre and surgical practices, post-operative practices, equipment maintenance 
guidelines, cleaning and sterilisation practices and microbiological screening. Five cases of 
endophthalmitis following uncomplicated phacoemulsification, by different surgeons, were noted over a 
7-month period. Three cultures grew Streptococcus viridans of different strains, 1 culture grew 
Staphylococcus aureus and no organisms grew on the last culture. Without a single causative factor, it was 
30 
 
postulated that it was a combined effect of many possible factors that led to increased bacterial load and 
subsequent infection rate. Recommendations were made which included new cleaning protocols to 
prevent the build-up of debris on the phacoemulsification tubing.  
In another article by Lesley et al (5) the importance of meticulous cleaning of phaco hand pieces to 
prevent endophthalmitis was elaborated. Automated flushing is superior to manual cleaning of the 
instruments in preventing interpatient transfer of infection. Automated flushing did not, however, 
eliminate contamination but it decreased it (6). In other branches of medicine manual cleaning and 
flushing of instruments with small lumens prior to sterilization proved more effective in eliminating inter 
patient contamination.  
Studies have looked at cross infection from contaminated phaco hand pieces and irrigating fluid. 
There is no study that has solely looked at the role of tubing in isolation. One such study was done in 2014 
at the University of Sao Paulo where they found viral contamination of phaco probes and tubing, gloves, 
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3. AIMS AND OBJECTIVES 
3.1. Aim:  
To assess if phacoemulsification tubing remains sterile during sequential phacoemulsification. 
 
3.2. Objectives:  
To draft a protocol regarding re-using phaco tubing during sequential phacoemulsification. 
To investigate if there is growth of micro- organisms from phaco tubing that are re-used in sequential 
phacoemulsification at the two of three sites. 
To investigate and compare micro-organisms, if identified, from each specimen (piece of sterile phaco 
tubing) that will be sent for culture 
 
4. METHODS 
The study will be conducted at Greys Hospital, Edendale Hospital and Northdale Hospital over a one-
month period. Routine phaco procedure will be done as per hospital guidelines. Just before the tubing is 
discarded, a piece will be cut off, placed in a sterile specimen container and sent to the laboratory. At the 
laboratory it will then be incubated in a Broth medium overnight then transferred on to Agar plates for 
culture.  
• We will use these three hospitals because they all currently have different protocols on used 
phacoemulsification tubing: 
• At Greys Hospital new phaco tubing is used for each case.  
• At Edendale Hospital, phaco tubing is reused on three sequential patients on one slate.  
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• At Northdale Hospital one phaco tubing is used for the entire slate of six patients.  
Patient details will not be recorded.  
 
4.1. Study Design 
This is an analytical cross sectional study.  
 
4.2. Setting 
The study will be conducted at Greys Hospital, Edendale Hospital and Northdale Hospital in 
Pietermaritzburg, KwaZulu-Natal, South Africa. 
Permission has not been granted yet - awaiting BREC approval. 
 
4.3. Participant Selection 
This is a study of a surgical device and not people. All used phacoemulsification tubing will be 
microscopically analysed.  
 
4.4. Measurements 
Each piece of tubing sent as a specimen will be incubated in a Broth medium and then transferred to 
Agar plate for culture. There are no studies done where irrigation tubing were cultured, one study that 
comes close was the study on CVP tips. CVP tips were cultured and compared with blood culture. In this 
study, the microscopic results from each piece of phaco tubing will be analysed. Bacteria that usually grow 
in tubes include Staphylococcus Epidermidis, Staphylococcus aureus and Pseudomonas.  As this is sterile 
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tubing, no growth is expected on culture. Any growth will therefore be significant. Specimens from the 
different hospitals will be compared and so will the results. It will be interesting to note whether after six 
cases the density of growth or the number of micro-organisms will be more after six cases when compared 
to three or one case.  Recommendations based on microscopic evidence will be made.     
 
4.5. Data Selection and Statistical Analysis 
 
Data selection  
Phacoemulsification cases will be selected as per theatre booking. Before the tubing is discarded a 
piece will be cut and placed in a sterile bag before being sent to the laboratory. Data collection will start 
from 01/08/2016 until 31/08/2016.  
 
Statistical analysis 
 We will report the incidence and 95% confidence interval of bacterial growth for each hospital. The 
difference in both incidence and density of growth will be analysed using Fisher exact test.   
 











Study Number of 
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4.5.2. Sample size 
A total sample size is estimated at about 76 phacoemulsification tubing will be microscopically 
analysed. About 12 tubing will be collected from Northdale Hospital, 28 tubing from Greys Hospital and 
40 tubing from Edendale Hospital. Statistical calculations will calculate the accuracy of our estimate of 
average and range. 
 
  5. ETHICAL CONSIDERATIONS 
Patients will not be enrolled for the study. No patient consent or record is required. The state 
laboratory will be used to analyse our phacoemulsification tubing. Future patients will benefit because 
recommendations will be made to improve patient safety by maintaining sterility. Conflict of interest may 





Table 2: Budget 
Item Description Cost 
stationery R500 
Petrol R200 
Northdale Hospital R1200 
Edendale Hospital R4000 
Greys Hospital R2800 
Total Project Cost R8700 
We have liaised with the Northdale Hospital Microbiology Laboratory and they will assist us 
with this study. 
The author will not be seeking funding for this project. 
 
7. TIME LINES AND PROJECT MANAGEMENT 
Phacoemulsification is performed twice per week at Northdale Hospital and at Greys Hospital. It is 
performed daily at Edendale Hospital. Specimens will be collected by the surgeon, marked for the study 
and sent to the laboratory. 
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The collection of data will take place in August 2016 (pending bioethical approval). Write-up of the 
study will be completed before the end of 2016. 
 
8. CONTRIBUTORS AND AUTHORSHIP 
Table 3: Contributors and Authorship 
Name Department Department 
Author or 
acknowledgement 
Dr L T 
Ndlovu Ophthalmology Principal Investigator Author 
Dr C Kruse Ophthalmology Supervisor acknowledgement 
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The format of the compulsory cover letter forms part of your submission. It is located on the 
first page of your manuscript and should always be presented in English. You should provide the 
following elements: 
Full title: Specific, descriptive, concise, and comprehensible to readers outside the field, max 
95 characters (including spaces). 
Tweet for the journal Twitter profile: This will be used on the journal Twitter profile to 
promote your published article. Max 101 characters (including spaces). If you have a Twitter 
profile, please provide us your Twitter @ name. We will tag you to the Tweet 
Full author details: The title(s), full name(s), position(s), affiliation(s) and contact details 
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Identification (ORCID) and cell phone number) of each author. 
Corresponding author: Identify to whom all correspondence should be addressed. 
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Original Research Article full structure 
 
Title: The article’s full title should contain a maximum of 95 characters (including spaces). 
  
Abstract: The abstract, written in English, should be no longer than 250 words and must be 
written in the past tense. The abstract should give a succinct account of the objectives, methods, 
results and significance of the matter. The structured abstract for an Original Research article 
should consist of six paragraphs labelled Background, Aim, Setting, Methods, Results and 
Conclusion. 
Background: Summarise the social value (importance, relevance) and scientific value 
(knowledge gap) that your study addresses. 
Aim: State the overall aim of the study. 
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Setting: State the setting for the study. 
Methods: Clearly express the basic design of the study, and name or briefly describe the 
methods used without going into excessive detail. 
Results: State the main findings. 
Conclusion: State your conclusion and any key implications or recommendations. 
Do not cite references and do not use abbreviations excessively in the abstract. 
  
Introduction: The introduction must contain your argument for the social and scientific value 
of the study, as well as the aim and objectives: 
Social value: The first part of the introduction should make a clear and logical argument for 
the importance or relevance of the study. Your argument should be supported by use of evidence 
from the literature. 
Scientific value: The second part of the introduction should make a clear and logical argument 
for the originality of the study. This should include a summary of what is already known about 
the research question or specific topic, and should clarify the knowledge gap that this study will 
address. Your argument should be supported by use of evidence from the literature. 
Conceptual framework: In some research articles it will also be important to describe the 
underlying theoretical basis for the research and how these theories are linked together in a 
conceptual framework. The theoretical evidence used to construct the conceptual framework 
should be referenced from the literature. 
Aim and objectives: The introduction should conclude with a clear summary of the aim and 
objectives of this study. 
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Study design: An outline of the type of study design. 
Setting: A description of the setting for the study; for example, the type of community from 
which the participants came or the nature of the health system and services in which the study 
is conducted. 
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exclusion criteria. Describe the intended sample size and your sample size calculation or 
justification. Describe the sampling strategy used. Describe in practical terms how this was 
implemented. 
Intervention (if appropriate): If there were intervention and comparison groups, describe the 
intervention in detail and what happened to the comparison groups. 
Data collection: Define the data collection tools that were used and their validity. Describe in 
practical terms how data were collected and any key issues involved, e.g. language barriers. 
Data analysis: Describe how data were captured, checked and cleaned. Describe the analysis 
process, for example, the statistical tests used or steps followed in qualitative data analysis. 
Ethical considerations: Approval must have been obtained for all studies from the author's 
institution or other relevant ethics committee and the institution’s name and permit numbers 
should be stated here. 
Results: Present the results of your study in a logical sequence that addresses the aim and 
objectives of your study. Use tables and figures as required to present your findings. Use 
quotations as required to establish your interpretation of qualitative data. All units should 
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the reader should take into account when interpreting your results. 
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Appendix 3: Ethical approvals 
GREYS HOSPITAL 
OFFICE OF THE CEO 
Private Bag X 9001, Pietermaritzburg, 3200 
Town Bush Road, Chase Valley, Pietermaritzburg, 3201 
Tel.:033 - 897 3321 Fax: 033 - 8973398 
To: Dr L.T. Ndlovu     Department of Ophthalmology - Grey's Hospital cc: Mr. B. Bond - NY-
ILS Laboratory —Grey 's Hospital 
From: Mrs. K.T. McKenzie               Acting CEO - Grey s Hospital 
Date: 9 November 2016 
Re: Request for permission to conduct research: A microscopic analysis of new versus multi-
used phacoemulsification tubing in maintaining sterility and improving patient safety 
Dear Dr Ndlovu 
 
Your request to conduct research at Grey's Hospital refers. 
 
Permission to conduct the above study is hereby granted under the following conditions:  Your 
provisional ethics approval and research protocol are assumed to be valid and final ethics approval is a 
prerequisite for conducting your study at our hospital. Once obtained from BREC, please submit a copy of 
the full ethics approval; 
You are also required to obtain approval for your study from the Provincial Department of Health KZN 
Health Research Unit (HRKMU) prior to commencing your study at Grey's Hospital. You will find more 
information on their website: http: www.kznheallh.gov.za/hrkm.htm 
Confidentiality of hospital information, including staff and patient medical and/or contact 
information, must be kept at all times; Patient records are not to be removed from the hospital premises 
nor are you allowed to photocopy/ photograph them. 
You are to comply with the data collection process described in your attached email, and 
segregate research resources (tubing, laboratory specimens, etc.) from Grey's hospital's 
resources to avoid charges to the hospital. Non-compliance thereof will result in retraction of 
gatekeeper permission and reporting this to BREC and HRKMU.  You are to ensure that your data 
collection process will not interfere with the routine services at the hospital; 
Informed consent is to be obtained from all participants in your study, if applicable; 
Policies, guidelines and protocols of the Department of Health and Grey's Hospital must be adhered 
to at all times; 
Professional attitude and behaviour whilst dealing with research participants must be exhibited; 
The Department of Health, hospital and its staff will not be held responsible for any negative incidents 
and/or consequences, including injuries and illnesses that may be contracted on site, litigation matters, 
etc. that may arise as a result of your study or your presence on site;  You are required to submit to this 
office a summary of study findings upon completion of your research. 
You are requested to make contact with the HCD of Surgery, Dr Govindasamy, at Grey's Hospital once 
you are ready to commence data collection. 
 
Recommended by      Approved by 
Dr L Naidoo      Mrs. .T. McKenzie 
Senior Manager- Medical Services           Acting Hospital CEO 










19 July 2016 
Dr Carl-Heinz Kruse 
Dept. of Ophthalmology 
 
MMED PROTOCOL: "A microscopic analysis of new VERSUS multi-used phacoemulsification tubing in 
maintaining sterility and improving patient safety" 
 
Student: Dr LT Ndlovu, Student Number: (Department of Ophthalmology) 
 
I am pleased to inform you that the abovementioned protocol has been approved. 
 
Please note: 
The Academic Leader: School Research must review any changes made to this study. 
The study may not begin without the approval of the Biomedical Research Ethics Committee. 
, A copy of the full ethics approval letter should be forwarded to the Postgraduate Office. 
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BIOMEDICAL RESEARCH ETHICS COMMITTEE  
 
APPLICATION FOR ETHICS APPROVAL OF AMENDMENTS 
 
 NAME OF RESEARCHER: Dr Lungile Thandeka Ndlovu  
 DEPARTMENT: Ophthalmology  
 TITLE OF STUDY: A microscopic analysis of new VERSUS used phacoemulsification tubing in 
maintaining sterility and improving patient safety  
 ETHICS REFERENCE NO: BE450/16  
 DATE OF ETHICAL APPROVAL OF STUDY: 11/01/2017  
 DATE OF AMENDMENTS: 10/04/2017  
 
 AMENDMENTS REQUESTED:  
 Protocol states: in 4.5.2 (sample size)  
A total sample size is estimated at about 76phacoemulsification tubing which will be 
microscopically analysed. About 12 tubing will be collected from Northdale Hospital, 28 tubing 
from Greys Hospital and 40 tubing from Edendale Hospital.  
 
 Amendment requested  
Removal of Northdale Hospital as one of the participants in this study.   
 
 Reason for amendment  
This amendment is necessary as Northdale Hospital has suspended all ocular surgery as from 
01/04/2017. No phacoemulsification procedures will be done until a permanent doctor is 
employed by the hospital or Greys Hospital Eye Clinic has enough staff to send a doctor to 
Northdale to assist with ocular surgery.  This study will then only compare two hospitals, Greys 
Hospital and Edendale Hospital. This will not affect the study negatively as Edendale Hospital just 
















13 December 2016 
 
Dear Dr L T Ndlovu 
(University of KwaZulu-Natal) 
 
Subject: Approval of a Research Proposal 
 
The research proposal titled 'A microscopic analysis of new VERSUS reused 
phacoemulsification tubing in maintaining sterility and improving patient safety' was reviewed 
by the KwaZulu-Natal Department of Health (KZN-DoH). 
 
The proposal is hereby approved for research to be undertaken at Greys, Northdale and 
Edendale Hospitals. 
 
You are requested to take note of the following: 
Make the necessary arrangement with the identified facility before commencing with your 
research project. 
Provide an interim progress report and final report (electronic and hard copies) when your 
research is complete. 
Your final report must be posted to HEALTH RESEARCH AND KNOWLEDGE MANAGEMENT, 10-102, 
PRIVATE BAG X9051, PIETERMARITZBURG, 3200 and e-mail an electronic copy to hrkm@kznhealth.qov.za 
 





Dr E Lutge 
Chairperson, Health Research Committee 
Date: U  
 




Appendix 4: Raw data (example) 
 
 
FULL FINAL LABORATORY REPORT 
PATIENT :        REPORT TO: 
Control 3 PHACO STUDY    
DOB not stated Sex - Sample Ref : ABCU0572D DR NDLOVU 
 Collected: 18/04/2017   
 Received : 18/04/2017 10:10 Study: Dr LT Ndlovu 
 1st Print: 23/04/2017 16 :20 37 Forsdick Road 
 Reprint : 06/06/2017 14:23 Carrington Heights 
KwaZuIu-NataI    4001 
Patient Location: Study: Dr LT Ndlovu,  
FOR ENQUIRIES AND FOLLOW-UP TESTS, PLEASE QUOTE PATIENT'S MRN NUMBER MRN70490666 
 
MICROBIOLOGY 
Specimen received: Miscellaneous Tests requested: Cult 
Bacterial Culture : 
No growth after 2 days 
Authorised by: ZS zwane (Medical Technologist) Cult 
End of Laboratory Report   
NATIONAL HEALTH NORTHDALE LABORATORY 
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FULL FINAL LABORATORY REPORT 
      
 PATIENT :       REPORT TO: 
Control 4 PHACO STUDY    
DOB not stated Sex - Sample Ref : ABGU0573D DR NDLOVU 
 Collected: 18/04/2017   
 Received : 18/04/2017 10:42 Study: Dr LT Ndlovu 
 1st Print: 23/04/2017 16 :20 37 Forsdick Road 
 Reprint : 06/06/2017 14:24 Carrington Heights 
KwaZuIu-NataI    4001 
Patient Location: Study: Dr LT Ndlovu,  
 
FOR ENQUIRIES AND FOLLOW-UP TESTS, PLEASE QUOTE PATIENT'S MRN NUMBER MRN70490576 
 
MICROBIOLOGY 
Specimen received : Miscellaneous Tests requested: Cult 
Bacterial Culture: 
No growth after 2 days 
Authorised by: ZS Zwane (Medical Technologist) Cult 
End of Laboratory Report  
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